The Biden administration has unveiled a groundbreaking proposal aimed at enhancing accessibility to contraceptive products. This initiative seeks to make over-the-counter birth control and condoms available at no cost for women of reproductive age who have private health insurance.
Announced by the U.S. Department of Health and Human Services (HHS), Labor Department, and Treasury Department, the proposed changes would require health insurance companies to cover recommended over-the-counter contraceptive options—including condoms, spermicide, and emergency contraception—without the need for a prescription, ensuring they are provided at no cost.
Additionally, private health insurance providers would be mandated to inform recipients about the over-the-counter products that are covered.
This move is timed with the Biden administration’s broader efforts to improve access to contraceptives amidst a political landscape where reproductive health, particularly abortion, has become a contentious topic heading into the 2024 presidential election. Following the Supreme Court’s decision to overturn Roe v. Wade in 2022, many Republican-led states have enacted strict abortion limitations, leading to sharp declines in prescriptions for birth control and emergency contraceptives.
HHS Secretary Xavier Becerra highlighted that imposing burdensome requirements by insurers often complicates access to contraceptives.
“Women have expressed their challenges in accessing specific brands of birth control due to cost discrepancies in their health coverage,” Becerra stated. “This proposed rule reinforces the Affordable Care Act’s commitment to provide women’s preventive services without cost sharing, ensuring wider accessibility to contraception.”
Under the new proposal, individuals would be able to obtain these products similarly to prescription medications, available at pharmacies or through reimbursement, depending on individual health plans.
Previously, the Affordable Care Act allowed for no-copay birth control prescriptions, which required a doctor’s authorization. However, in July 2023, the FDA approved Opill, the first over-the-counter birth control pill, which became available for purchase online for $19.99.
Earlier this year, the Biden administration took steps to bolster access to both abortion and contraceptives, including guidance from the Office of Personnel Management aimed at federal workers and their families.
The period for public commentary on the proposed rule will open shortly, and if enacted, it could take effect as early as 2025. However, a potential shift in administration could bring changes to or the reversal of this rule.